Clinical Trial Update: A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures. [Phase 3]

View source ↗

Summary

Phase 3 trial updating on the effectiveness, safety, and tolerability of carisbamate as add-on therapy for partial-onset seizures. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy
• Focal Motor Seizures
• Partial-onset Seizures
• Simple Partial Seizures

Drugs mentioned

• carisbamate (carisbamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Epilepsy, Partial, Motor, Epilepsy, Complex Partial | Phase 3 | Status: COMPLETED